Anesthesia protol for cat for neutering Explanation in detailed

Reading File
Now let me search the medical library and web in parallel for feline anesthesia neutering protocols.
Finding Sources
Finding Sources
Searching the Web

feline cat neutering anesthesia protocol veterinary 2024

Good - I have excellent sources. Let me extract the full content from the two most authoritative guidelines (RSPCA/Cat Anaesthesia Guidelines and WSAVA).
Reading Web Page

https://rspca.sfo2.cdn.digitaloceanspaces.com/public/Uploads…

Finding Sources
Finding Sources
I now have comprehensive data from WSAVA 2024 and RSPCA/Cat Anaesthesia Guidelines. Let me compose the full detailed answer.

Anesthesia Protocol for Cat Neutering (Male Castration & Female OVH/OVE)


1. Pre-Anesthetic Assessment

Before any drug is given, a thorough pre-anesthetic evaluation is mandatory.
Physical examination includes:
  • Body weight (dosing is weight-based)
  • Cardiovascular and respiratory auscultation
  • Mucous membrane color and CRT
  • Hydration status
  • Temperature
  • Assessment of temperament and stress level
ASA Physical Status Classification:
ClassDescriptionExample
PS 1Normal, no organic diseaseElective neutering - healthy cat
PS 2Mild systemic diseaseSkin tumor, no shock
PS 3Severe systemic disease, limiting activityWell-controlled diabetes
PS 4Incapacitating disease, constant threat to lifePerforated bowel + hypovolemia
PS 5Moribund, not expected to survive 24h without surgerySevere trauma and shock
Most cats presented for elective neutering are PS 1 or PS 2.
Fasting guidelines:
  • Adults: withhold food 4-6 hours pre-op; water can generally be allowed up to the time of premedication
  • Neonates/kittens (< 8 weeks): limit fasting to 1-2 hours to avoid hypoglycemia
  • Geriatric cats: reduce fasting time; monitor glucose
Special considerations for kittens (0-6 months):
  • Immature P450 enzyme system - variable drug metabolism until ~5 months
  • Highly susceptible to hypothermia during anesthesia
  • Use lower end of all dose ranges

2. Equipment Preparation

Always prepare and check all equipment BEFORE premedication.
  • Endotracheal tubes (2.5-4.5 mm ID for most adult cats)
  • Laryngoscope
  • Oxygen source and breathing circuit (T-piece/Bain circuit for cats < 10 kg)
  • Monitoring equipment: pulse oximeter, capnograph, blood pressure monitor, ECG, thermometer
  • IV catheters (22-24 G), flush, tape
  • Emergency drugs ready: atropine, epinephrine
  • Warm environment/heat mat to prevent hypothermia
  • Anesthesia machine checked and leak-tested

3. Premedication (Phase 1)

Premedication serves four purposes: anxiolysis/sedation, analgesia, reduction of induction drug requirements (sparing effect), and smoother recovery.

Route and Timing

  • IM or SC injection, in a quiet environment
  • Allow 15-30 minutes (IM) for full effect before induction
  • After giving premedication, place the cat in a quiet, warm, dark cage to minimize stimulation

A. For Calm/Easy-to-Handle Cats (Light-Moderate Sedation)

Option 1 - Opioid + Acepromazine (Neuroleptanalgesia):
  • Butorphanol 0.2-0.4 mg/kg IM + Acepromazine 0.01-0.05 mg/kg IM
  • Buprenorphine 0.02 mg/kg IM or OTM (oral transmucosal)
Option 2 - Opioid + Alpha-2 Agonist:
  • Butorphanol 0.2-0.4 mg/kg IM + Medetomidine 0.01-0.04 mg/kg IM OR
  • Butorphanol + Dexmedetomidine 5-20 mcg/kg IM

B. For Fractious/Nervous/Unsocialized Cats (Moderate-Heavy Sedation)

Option - Triple combination (IMM or "kitty magic"):
  • Medetomidine (0.04-0.08 mg/kg) + Butorphanol (0.2-0.4 mg/kg) + Ketamine (2-5 mg/kg) IM
  • Dexmedetomidine (10-20 mcg/kg) + Butorphanol (0.2 mg/kg) + Ketamine (5 mg/kg) IM
Alfaxalone alone (if no controlled drugs available):
  • Alfaxalone 5-10 mg/kg IM - note: provides NO analgesia; additional analgesics are mandatory
Tiletamine/Zolazepam (Telazol):
  • 3-4 mg/kg IM - provides restraint and anesthesia; recovery can be prolonged

C. Pre-op Analgesia - Always Include

  • NSAID (meloxicam 0.2 mg/kg SC or PO, once-only) at or before premedication
  • Opioid as part of premedication (see above)
  • Together these form multimodal analgesia

Notes on Drug Classes

Drug ClassExample DrugsRoleReversal Agent
OpioidsButorphanol, Buprenorphine, MorphineAnalgesia, sedationNaloxone
Alpha-2 agonistsMedetomidine, DexmedetomidineProfound sedation, analgesiaAtipamezole
PhenothiazinesAcepromazineAnxiolysis, anti-emeticNone (no reversal)
DissociativesKetamineAnesthesia, analgesiaNone (metabolized)
NSAIDsMeloxicam, CarprofenAnalgesia, anti-inflammatoryNone
BenzodiazepinesMidazolam, DiazepamSedation, muscle relaxationFlumazenil

4. Induction of Anesthesia (Phase 2)

IV induction is preferred wherever possible as it allows titration to effect.
First: place an IV catheter (cephalic or saphenous vein, 22-24 G) after premedication takes effect.

IV Induction Options

AgentDose (IV)Notes
Propofol3-10 mg/kg slow IV to effectGive slowly over 60 seconds to reduce apnea. Dose is LOWER if alpha-2 used in premedication
Alfaxalone1-3 mg/kg IV to effectSmoother recovery than propofol in cats; give slowly
Ketamine + MidazolamKetamine 3-5 mg/kg + Midazolam 0.25 mg/kg IVGood for cats where alpha-2 is contraindicated
Ketamine + DiazepamKetamine 3-5 mg/kg + Diazepam 0.25 mg/kg IVSimilar to midazolam combination
Dose reduction rule: If an alpha-2 agonist was used in premedication, reduce all IV induction drug doses by 30-50%.

IM Induction (when IV access is not possible)

CombinationDose
Alpha-2 agonist + KetamineMedetomidine 0.04-0.08 mg/kg + Ketamine 5-10 mg/kg IM
Tiletamine/Zolazepam3-4 mg/kg IM

Intubation

  • After induction, endotracheal intubation is strongly recommended for:
    • Procedures > 5 minutes
    • Cats maintained on inhalant
    • Airway protection
  • Cats have a narrow glottis - apply topical lidocaine to the larynx (1-2 sprays of 2% lidocaine) 30-60 seconds before intubation to prevent laryngospasm
  • Use the smallest tube that allows adequate ventilation (2.5-4.0 mm ID typical)
  • Confirm placement by capnography (CO2 waveform) and bilateral chest auscultation

5. Maintenance of Anesthesia (Phase 3)

Inhalant (Gas) Anesthesia - Preferred for Longer Procedures

  • Isoflurane: 1.5-2.5% in oxygen (most common)
  • Sevoflurane: 2.5-3.5% in oxygen (faster induction/recovery, good for mask induction in kittens)
  • Delivered via a T-piece or Bain breathing circuit (for cats < 10 kg)
  • Oxygen flow: 200-500 mL/kg/min for non-rebreathing circuits
For male cat castration: In many cases the procedure is brief (5-10 min) and no maintenance drugs are needed - the premedication + induction agent provides sufficient duration. Always have a plan ready to extend anesthesia if needed.

Injectable Maintenance (if inhalant not available)

  • Ketamine IV: 1/3 to 1/2 of initial induction dose as boluses as needed
  • Propofol CRI: 0.1-0.4 mg/kg/min IV infusion
  • Alfaxalone CRI or boluses: 1-3 mg/kg IV as needed

6. Local Anesthetic Techniques (Highly Recommended)

These reduce intraoperative and postoperative pain dramatically and reduce the amount of systemic drugs needed.

For Male Castration:

  • Intratesticular block: Lidocaine 1-2 mg/kg per testis, injected directly into the testicular parenchyma before incision
  • Incisional infiltration: Lidocaine SC along the incision line, pre- or post-surgery

For Female OVH/OVE:

  • Incisional (line) block: Lidocaine SC along the flank/midline incision
  • Intraperitoneal/ovarian ligament block: Lidocaine 1-2 mg/kg dripped onto the ovarian pedicle and ligament before clamping
Lidocaine dosing note: Maximum dose in cats = 4 mg/kg (cats are very sensitive to lidocaine toxicity - NEVER exceed this dose). Use 1-2% lidocaine. Bupivacaine (1-2 mg/kg) can be used for longer-lasting block (~4-6 hours) but has a narrower safety margin.

7. Monitoring During Anesthesia

Continuous monitoring is mandatory from induction through recovery.
ParameterMethodTarget / Alert
Depth of anesthesiaEye position, jaw tone, pedal withdrawal reflex, palpebral reflexAppropriate depth for stage of surgery
Heart rateECG, pulse oximeter, Doppler100-180 bpm; < 80 = concern
SpO2Pulse oximeter> 95%; < 90% = emergency
End-tidal CO2Capnography35-45 mmHg; > 55 = hypoventilation
Respiratory rateVisual / capnograph10-20 breaths/min
Blood pressureDoppler (gold standard in cats) / oscillometryMean > 60 mmHg; systolic > 80 mmHg
TemperatureRectal or esophageal probe37.5-39.2°C; hypothermia (< 37°C) is very common
Mucous membranesDirect visualPink, moist; CRT < 2 seconds

8. Supportive Therapies

Fluid Therapy

  • Healthy cats undergoing brief elective procedures: fluids are optional but recommended
  • Rate: 3-5 mL/kg/hour IV crystalloid (e.g., Hartmann's/LRS or 0.9% NaCl)
  • Increase if hypotension detected

Hypothermia Prevention

  • Cats lose body heat rapidly under anesthesia
  • Use: warm IV fluids, heat mat (never electric on direct contact - use circulating warm water), forced-air warming blanket
  • Target temperature: maintain > 37°C throughout

Eye Care

  • Cats often lose the blink reflex under anesthesia
  • Apply ophthalmic lubricant (artificial tears/eye ointment) to both eyes immediately after induction and repeat every 20-30 minutes

9. Standard Protocol Summary Tables

Male Cat Castration - Full Protocol (Preferred, with Controlled Drugs)

PhaseDrugDoseRouteTiming
PremedicationMeloxicam0.2 mg/kgSC30 min pre-op
Dexmedetomidine10-20 mcg/kgIM15-30 min pre-op
Butorphanol0.2-0.4 mg/kgIM15-30 min pre-op
Local blockLidocaine 2%1-2 mg/kg per testisIntratesticularAt time of surgery
InductionPropofol OR Alfaxalone1-4 mg/kg to effectIV slowAfter premedication
MaintenanceIsoflurane1.5-2%InhalantBrief procedure; may not be needed
Post-opMeloxicam (cont.)0.05 mg/kg SIDPO1-3 days at home

Male Cat Castration - Without Controlled Drugs

PhaseDrugDoseRoute
PremedicationNSAID + Alpha-2 agonistAs aboveSC/IM
InductionAlpha-2 + KetamineMedetomidine 0.06 mg/kg + Ketamine 5-10 mg/kgIM
MaintenanceInhalant or ketamine top-upsAs needed-

Female Cat OVH/OVE - Preferred Protocol

PhaseDrugDoseRoute
PremedicationOpioid (butorphanol or buprenorphine) + Acepromazine OR Alpha-2 agonistStandard doses aboveIM
Meloxicam0.2 mg/kgSC
InductionPropofol to effect OR Alfaxalone3-10 mg/kg (lower if alpha-2 used)IV
IntubationLidocaine spray1-2 sprays to larynxTopical
MaintenanceIsoflurane1.5-2.5%Inhalant
Local blockLidocaine1-2 mg/kgIncisional + intraperitoneal
Post-opMeloxicam0.05 mg/kg SID x 3 daysPO

10. Recovery Phase

  • Place cat in a quiet, warm, padded cage with sternal recumbency positioning
  • Extubate when the swallowing reflex returns (cat attempts to chew the tube)
  • Monitor continuously until standing and alert
  • Maintain body temperature - provide warm bedding/heat source
  • Assess pain score on recovery (2-3 hours post-op and before discharge)
  • Use validated feline pain scoring tool (e.g., UNESP-Botucatu, Glasgow Composite Pain Scale)
  • If pain score is elevated: administer rescue analgesia (buprenorphine 0.02 mg/kg OTM or IV fentanyl 1-3 mcg/kg)

Pain indicators in cats:

  • Orbital tightening / squinting
  • Muzzle/whisker pad tension
  • Ear position (flattened)
  • Head position (lowered, tucked)
  • Body posture (hunched, reluctant to move)
  • Vocalization
  • Guarding the surgical site

11. Drug Reversal

Drug UsedReversal AgentDoseRouteNotes
Medetomidine/DexmedetomidineAtipamezole5x the dexmedetomidine dose (mcg/kg); same volume as medetomidine usedIMDo NOT give until at least 30-45 min post-surgery; reversal is rapid
Opioids (if needed)Naloxone0.01-0.04 mg/kgIV/IMOnly for respiratory emergency; also reverses analgesia
Benzodiazepines (if needed)Flumazenil0.01-0.1 mg/kgIVRarely needed
Acepromazine has no reversal agent. Atimuscarinic drugs (atropine, glycopyrrolate) are NOT routinely given but may be used intra-operatively for opioid-induced bradycardia causing hypotension (atropine 0.01-0.02 mg/kg IV).

12. Common Complications and Management

ComplicationCauseManagement
HypothermiaHeat loss under anesthesiaActive warming, warm fluids
HypotensionAnesthetic depth, vasodilationReduce gas %, fluid bolus 5-10 mL/kg, atropine if bradycardia-driven
BradycardiaOpioids, alpha-2 agonistsAtropine 0.01-0.02 mg/kg IV (not for alpha-2-induced bradycardia - treat with atipamezole)
LaryngospasmIntubation without lidocainePre-spray larynx, wait 60 sec, use small tube
Apnea/hypoventilationPropofol bolus, deep inhalantAssist ventilation, reduce agent concentration
Prolonged recoveryTiletamine/zolazepam, hypothermiaRewarm, supportive care; no specific reversal for tiletamine

Key takeaways:
  1. Multimodal analgesia (NSAID + opioid + local block) is the standard of care - never rely on a single drug class.
  2. Dose reduction is essential when combining drugs - premedication significantly reduces induction requirements.
  3. Temperature monitoring and active warming are as important as the drug protocol.
  4. Local anesthetic blocks (intratesticular for males; incisional/intraperitoneal for females) should be used in every case.
  5. Atipamezole reversal of alpha-2 agonists should be delayed until the procedure is complete to avoid pain/excitation.

Dose rate of ivermectin in dogs

Ivermectin in dogs is used at varying doses depending on the indication. For heartworm prevention it's given at very low doses (6-12 mcg/kg monthly), while mange treatment requires much higher doses (200-400 mcg/kg). The drug is contraindicated in Collies and related breeds due to the MDR1/ABCB1 gene mutation.
Searching sources...
Finding Sources
Finding Sources
Searching the Web

ivermectin dose rate dogs indications heartworm mange microfilaria veterinary 2024

Now let me read the relevant textbook section from Katzung and Goodman & Gilman for pharmacological depth, and also pull the WSAVA/veterinary specific dosing.
Reading File
Reading File
Reading File
I now have all the information needed for a comprehensive answer. Let me compile it.

Ivermectin Dose Rates in Dogs - Complete Guide

1. Overview & Mechanism

Ivermectin is a semisynthetic macrocyclic lactone derived from Streptomyces avermitilis. It works by binding to glutamate-gated Cl⁻ channels (and GABA-gated Cl⁻ channels) in invertebrate nerve/muscle cells, causing hyperpolarization and tonic paralysis of parasites. These channels are absent in mammals, giving a wide safety margin - except in dogs with the MDR1/ABCB1 mutation, where the P-glycoprotein efflux pump that normally excludes ivermectin from the CNS is non-functional, allowing neurotoxic concentrations to accumulate in the brain.
  • Goodman & Gilman notes: "the drug causes significant neurotoxicity in some species such as the beagle dog" and penetration across the BBB is normally prevented by ABCB1/MDR1/P-glycoprotein.

2. Dose Rates by Indication

IndicationDoseRouteFrequencyNotes
Heartworm prevention (D. immitis L3/L4 larvae)6-12 mcg/kg (0.006-0.012 mg/kg)POMonthlyHeartgard® standard dose; 6 mcg/kg confirmed 100% efficacy against early D. immitis
Microfilaricide (D. immitis microfilariae)50-200 mcg/kg (0.05-0.2 mg/kg)POSingle dose; repeat as neededUse with caution in heartworm-positive dogs - can cause anaphylactoid shock if microfilarial burden is high
Sarcoptic mange (Sarcoptes scabiei)200-400 mcg/kg (0.2-0.4 mg/kg)PO or SCEvery 1-2 weeks x 3-4 treatmentsHighly effective; 2-4 doses typically needed
Demodectic mange (Demodex canis)300-600 mcg/kg/day (0.3-0.6 mg/kg/day)PODaily; treat until 2 negative skin scrapings 1 month apartStart at 0.1 mg/kg/day and escalate by 0.1 mg/kg every 3 days; 85-90% cure rate at 0.6 mg/kg/day; treat 3-6 months
Cheyletiellosis (Cheyletiella spp.)200-300 mcg/kgPO or SCEvery 1-2 weeks x 3 dosesOff-label
Otodectic mange (Otodectes cynotis - ear mites)200-400 mcg/kgPO or SCRepeat in 2 weeksOff-label
Intestinal nematodes (hookworms, roundworms)200 mcg/kg (0.2 mg/kg)POSingle doseEffective against Toxocara, Ancylostoma
Capillaria200 mcg/kgPOSingle dose
Ticks/lice (off-label)200-400 mcg/kgPO/SCRepeat in 2 weeksVariable efficacy against ticks

3. Dose Escalation Protocol for Demodicosis (Important)

Because daily high-dose ivermectin for demodicosis carries toxicity risk, a gradual dose escalation is mandatory:
DayDose
Day 1-30.1 mg/kg/day PO
Day 4-60.2 mg/kg/day PO
Day 7-90.3 mg/kg/day PO
Day 10-120.4 mg/kg/day PO
Day 13-150.5 mg/kg/day PO
Day 16+0.6 mg/kg/day PO (therapeutic target)
  • Stop escalation immediately if any neurological signs appear (ataxia, mydriasis, tremors, depression)
  • Duration: continue until 2 negative skin scrapings taken 1 month apart - this often means 3-6 months total

4. Available Formulations

FormulationConcentrationCommon Use
Chewable tablet (Heartgard®)68 mcg or 136 mcg per tabletHeartworm prevention
Injectable solution 1% (Ivomec®)10 mg/mLLarge animal; used off-label PO in dogs
Oral solution 1% (Ivomec®)10 mg/mLOff-label oral use in dogs
Paste 1.87% (equine)18.7 mg/gOff-label; difficult to dose accurately in dogs
Topical (Acarexx®)0.01%Ear mites in cats
For off-label use of 1% injectable solution orally in dogs: at 0.1 mL/kg = 1 mg/kg = 1000 mcg/kg (far too high). Always dilute carefully. Many clinicians dilute 1% solution to 0.1% (1 mg/mL) in propylene glycol for easier dosing.

5. MDR1/ABCB1 Gene Mutation - Critical Safety Warning

Certain breeds carry a mutation in the MDR1 (ABCB1) gene that disables P-glycoprotein, the BBB efflux pump. In these dogs, even low heartworm-prevention doses can be toxic.
Breeds at risk (MDR1 mutation):
  • Collie (Rough and Smooth) - highest prevalence (~70%)
  • Shetland Sheepdog (Sheltie)
  • Australian Shepherd
  • Old English Sheepdog
  • Border Collie
  • McNab
  • White Swiss Shepherd
  • Silken Windhound
  • Long-haired Whippet
  • German Shepherd (low prevalence ~5%)
  • Mixed breeds with any of the above
In MDR1-mutant dogs:
  • Heartworm prevention doses (6-12 mcg/kg) are generally safe
  • Doses ≥ 100-200 mcg/kg can cause severe toxicity
  • Daily demodicosis doses (300-600 mcg/kg) are CONTRAINDICATED
Recommendation: Test all at-risk breeds with the ABCB1 gene mutation test (available via Washington State University VCPL) before using ivermectin at doses above 6-12 mcg/kg.

6. Signs of Ivermectin Toxicity in Dogs

Toxicity is dose-dependent and typically occurs above 2,000 mcg/kg in normal dogs (but at much lower doses in MDR1 mutants):
SeveritySigns
MildMydriasis (dilated pupils), ataxia, salivation
ModerateDisorientation, depression, vomiting, tremors
SevereBlindness, recumbency, seizures, respiratory depression
FatalComa, death (without treatment)
Treatment: No specific antidote. Supportive care - IV fluids, physostigmine (controversial), lipid emulsion therapy (IV fat emulsion 20%, has been used successfully to bind ivermectin in the vascular compartment).

7. Contraindications and Precautions

  • MDR1-mutant breeds at high doses (see above)
  • Puppies < 6 weeks - immature BBB; avoid or use with extreme caution
  • Pregnant/lactating bitches - generally considered safe at heartworm doses; caution at higher doses
  • Microfilaremic dogs - administering ivermectin at microfilaricidal doses can trigger a severe anaphylactoid/shock reaction due to rapid microfilarial death; pretreat with corticosteroids/antihistamines and keep under observation for 4-8 hours
  • Concurrent drugs - P-glycoprotein inhibitors (spinosad, ketoconazole, cyclosporine) can increase ivermectin CNS penetration and increase toxicity risk even in normal dogs

8. Quick Reference Summary Card

IVERMECTIN DOSE RATES IN DOGS
================================
Heartworm prevention:      6-12 mcg/kg  PO monthly
Microfilaricide:          50-200 mcg/kg PO single dose
Sarcoptic mange:         200-400 mcg/kg PO/SC q1-2wk x 3-4 doses
Intestinal nematodes:    200 mcg/kg    PO single dose
Otodectic/Cheyletiella:  200-400 mcg/kg PO/SC q2wk
Demodectic mange:        300-600 mcg/kg PO daily (escalate slowly)
                         treat until 2 neg scrapings 1 month apart

MDR1 mutation breeds: AVOID doses > 100 mcg/kg
This is a shared conversation. Sign in to Orris to start your own chat.